Previous Article in Journal
Different Physiochemical Properties of Novel Fibre Sources in the Diet of Weaned Pigs Influence Animal Performance, Nutrient Digestibility, and Caecal Fermentation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Animals
Volume 14
Issue 17
10.3390/ani14172613
animals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characterization of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius from Skin Lesions and Nasal Cavities of Dogs with Clinical Pyoderma

by
Putu Ayu Sisyawati Putriningsih
1,2,
Jaruwan Kampa
3,
Suphattra Jittimanee
3 and
Patchara Phuektes
3,*
1
Graduate School, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
2
Laboratory of Veterinary Internal Medicine, Faculty of Veterinary Medicine, Udayana University, Denpasar 80361, Indonesia
3
Division of Pathobiology, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
*
Author to whom correspondence should be addressed.
Animals 2024, 14(17), 2613; https://doi.org/10.3390/ani14172613 (registering DOI)
Submission received: 8 August 2024 / Revised: 2 September 2024 / Accepted: 4 September 2024 / Published: 8 September 2024
(This article belongs to the Section Companion Animals)
Browse Figures
Versions Notes

Abstract

:

Simple Summary

Staphylococcus pseudintermedius is a common bacterium that causes skin infections in dogs and can occasionally infect humans, posing a public health risk. The presence of the mecA gene in this bacterium can lead to resistance against methicillin (oxacillin) and other beta-lactam antibiotics, which limits treatment options. This study investigated the characteristics of oxacillin-resistant and oxacillin-susceptible mecA-positive S. pseudintermedius isolates from the skin and nasal cavities of dogs with pyoderma. We found a high prevalence of multidrug resistance and significant genetic diversity among the isolates, both within the dog itself and among others, highlighting the complexity of S. pseudintermedius colonization and infection dynamics in pyoderma dogs. Careful monitoring and treatment strategies are essential to manage the spread of antibiotic resistance effectively.

Abstract

Understanding the epidemiology of mecA-positive Staphylococcus pseudintermedius strains, including those that are oxacillin-susceptible but potentially inducible to resistance, is crucial for developing effective treatment strategies and mitigating public health risks. This study characterized 87 mecA-positive S. pseudintermedius isolates obtained from skin lesions and nasal orifices of 46 dogs with pyoderma enrolled at a referral hospital in Thailand between 2019 and 2020. All isolates underwent antibiogram profiling, SCCmec typing, and pulsed-field gel electrophoresis (PFGE) for phenotypic and genetic analysis. Among the 87 isolates, 33 isolates (37.9%) recovered from 15 dogs were oxacillin-resistant (OR-MRSP), while 54 isolates (62.1%) from 31 dogs were oxacillin-susceptible (OS-MRSP). All OR-MRSP isolates exhibited multidrug resistance (MDR), and 44% of the OS-MRSP isolates also showed MDR. SCCmec typing revealed type V as predominant among OR-MRSP isolates (69.7%), while many oxacillin-susceptible isolates (70.4%) were non-typeable. The OR-MRSP isolates from the same dog showed consistent antibiogram and SCCmec types, while OS-MRSP isolates displayed both identical and diverse patterns. No dominant pulsotypes were observed among the OR-MRSP or OS-MRSP strains. Genetic diversity was also noted among the isolates within the same dogs and among the others, highlighting the complexity of S. pseudintermedius colonization and infection dynamics in pyoderma-affected dogs.

1. Introduction

Staphylococcus pseudintermedius is an opportunistic pathogen naturally found on dogs’ skin, mucosae, and other body sites. With abnormalities of the skin condition, the bacteria can also provoke infections of the skin, ears, and other body tissues and cavities [1,2]. S. pseudintermedius is a major pathogenic microorganism encountered in companion animal dermatology practice [3] and is mainly found as secondary infections in dogs [4]. Human colonization and, occasionally, human infections by S. pseudintermedius have been reported sporadically [3,4,5,6], indicating the possibility that this bacterium can be zoonotic and may pose a public health problem.
Methicillin-resistant S. pseudintermedius (MRSP) is a strain of S. pseudintermedius that exhibits resistance to methicillin and penicillinase-stable beta-lactam antibiotics. This resistance is conferred by the mecA gene, which encodes a modified penicillin-binding protein 2a (PBP2a) [1]. MRSP is considered a reservoir for resistant genes to various antibiotics [7], as MRSP isolates are frequently multidrug-resistant (MDR), which is defined as resistance to at least one agent in three or more classes of antimicrobials [8]. In recent years, the frequency of MRSP detection in microbiological samples from dogs and cats has increased [1], posing a significant threat to veterinary medicine due to the limited therapeutic options available [9].
Apart from methicillin resistance, methicillin (oxacillin)-susceptible mecA-positive staphylococci have been increasingly identified globally [10,11,12,13,14]. Reports have documented Staphylococcus aureus isolates carrying the mecA gene while remaining phenotypically susceptible to oxacillin, termed oxacillin-susceptible MRSA (OS-MRSA). OS-MRSA can be inducible to resistance after antibiotic exposure [15], resulting in therapeutic failures with beta-lactam antimicrobials [16]. Importantly, a recent study detected OS-MRSA isolates in the nasal mucosa of healthy dogs and their owners [17]. In the case of S. pseudintermedius, the presence of mecA-positive strains that remain oxacillin-susceptible has not been comprehensively investigated and characterized. Given that mecA PCR is not routinely employed in laboratories, these strains may be unobserved, potentially facilitating their silent dissemination and posing challenges for effective treatment in infected dogs, particularly with bata-lactam antibiotics. Our previous study demonstrated a high prevalence of mecA-positive S. pseudintermedius in skin lesions of dogs with pyoderma; however, these strains have yet to be thoroughly characterized [18]. Therefore, this study aims to characterize and compare oxacillin-resistant and oxacillin-susceptible mecA-positive S. pseudintermedius isolates from dogs with clinical pyoderma. We also aim to compare infecting and colonizing strains within individuals and among the studied group. Understanding the epidemiology and characteristics of mecA-positive S. pseudintermedius strains is crucial for developing effective treatment strategies in veterinary clinical settings and for mitigating potential public health risks.

2. Materials and Methods

2.1. Sample Collection

Eighty-seven S. pseudintermedius isolates included in this study were obtained from 46 out of 63 enrolled dogs with pyoderma that visited the Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Khon Kaen University, between September 2019 and September 2020. Two skin swabs were collected from two separate lesions on each dog, and one nasal swab was obtained from each enrolled dog. These swabs were placed in a transport medium and stored at 4 °C before being cultured on blood agar, which contains a blood agar base supplemented with 5% defibrinated sheep blood (Clinical Diagnostics, Bangkok, Thailand). Inoculated plates were subsequently incubated at 37 °C under aerobic conditions for 18 to 48 h.

2.2. Isolation and Identification of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius

Staphylococci-like colonies grown on sheep blood agar were subjected to species identification based on their phenotype and genotype. All 87 isolates were phenotypically identified as S. pseudintermedius using the VITEK® 2 system (Biomerieux, Marcy l’etoile, France) and genotypically confirmed through polymerase chain reaction (PCR) targeting the nuc gene [19]. The mecA gene in each S. pseudintermedius isolate was detected using conventional PCR, following the protocol developed by Olivera [20], as previously described [18].
Antimicrobial susceptibility testing was performed using the VITEK® 2 system to identify oxacillin-resistant and oxacillin-susceptible isolates (Biomerieux, France). The antibiotics tested included oxacillin (OXA), benzylpenicillin (BEN), amoxicillin/clavulanic acid (AMC), cephalothin (CEP), cefpodoxime (CPD), cefovecin (CEV), amikacin (AMK), gentamicin (GEN), enrofloxacin (ENR), marbofloxacin (MAR), pradofloxacin (PRA), erythromycin (ERY), clindamycin (CLI), doxycycline (DOX), minocycline (MIN), nitrofurantoin (NIT), chloramphenicol (CHL), florfenicol (FLO), and trimethoprim/sulfamethoxazole (SXT). The minimum inhibitory concentration (MIC) of oxacillin was set at ≥0.5 μg/mL as an indicator of methicillin resistance; resistance to other antimicrobial agents was determined according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI) [21]. A disk diffusion test was also performed using a 1 µg oxacillin disk, with a cut-off of <20 mm used to determine resistance or susceptibility [22].

2.3. Pulsed-Field Gel Electrophoresis (PFGE)

The pulsed-field gel electrophoresis (PFGE) protocol was based on a prior study [23] with minor modifications. A CHEF-DR III system (Bio-Rad Laboratories, CA, USA) was used to conduct PFGE. All genomic DNA plugs were initially digested with SmaI (New England BioLabs Inc., MA, USA). Those isolates not digested by SmaI were subsequently digested with XmaI (New England BioLabs Inc., MA, USA). Cluster analysis was performed using the Unweighted Pair Group Method with Arithmetic Mean (UPGMA) in BIO-PROFIL Bio-1D++ software (Vilber Lourmat, Eberhardzell, Germany), employing the Dice similarity coefficient with a 2% interval of confidence for band matching. Isolates were clustered based on an 80% similarity cut-off.

2.4. SCCmec Typing

SCCmec typing was performed using two multiplex PCR sets (M-PCR 1 and M-PCR 2) described by Kondo et al. [24]. The first set (M-PCR 1) was used to detect the mecA gene and identify the ccr gene complex, while the second set (M-PCR 2) was employed to identify the mec gene complex. For M-PCR 1, the reaction mixture in a total volume of 25 µL contained 1x Qiagen Multiplex PCR Master Mix (Qiagen, Tegelen, The Netherlands), 10 pmol of each primer, 2 µL of extracted DNA, and RNase-free water to make up the volume. The PCR cycles consisted of an initial denaturation at 95 °C for 15 min, followed by 35 cycles of 94 °C for 2 min, 57 °C for 90 s, 72 °C for 2 min, and a final extension at 72 °C for 10 min. For M-PCR 2, the reaction mixture and reaction conditions were the same as for M-PCR 1, except that the annealing temperature was changed to 60 °C. DNA fragments were analyzed by electrophoresis in 1x TBE buffer on a 1.5% agarose gel stained with 1x Redsafe™ (iNtRON Biotechnology Inc., Seongnam, Republic of Korea).

2.5. Statistical Analysis

Statistical analyses were performed to assess the prevalence and associations of the isolates. Prevalence was calculated as a proportion of the total number of isolates or dogs and corresponding confidence intervals (CIs). The two-tailed Fisher’s exact test was used to evaluate the association between genotypic characteristics and phenotypes. This test was chosen due to the categorical nature of the data and the small sample sizes in some categories. A p-value of less than 0.05 was considered statistically significant. All statistical analyses and heatmaps were performed using GraphPad Prism version 10.0 for Windows (GraphPad Software, Boston, MA, USA; www.graphpad.com (accessed on 3 August 2024).

3. Results

3.1. Sample Origins and Distribution of S. pseudintermedius Isolates Positive for the mecA Gene

The 87 S. pseudintermedius isolates positive for the mecA gene comprised 67 skin isolates and 20 nasal isolates, which were recovered from 46 dogs out of 63 dogs (73%, 95% CI: 60.3–83.4). Only one isolate was obtained from each sampling site of an individual dog. Single skin isolates were obtained from nine dogs, and single nasal isolates from another six dogs. Seventeen dogs yielded two skin isolates each, while four dogs yielded both a skin and a nasal isolate. Ten dogs yielded two skin isolates and one nasal isolate, as shown in Table 1.
Based on an MIC value of ≥0.5 μg/mL and a zone diameter of <20 mm for a 1 µg oxacillin disk, 33 out of 87 isolates (37.9%) were identified as OR-MRSP, while 54 isolates (62.1%) were classified as OS-MRSP. The MIC values of the isolates were consistent with the results of the disk diffusion test. Among the 33 OR-MRSP isolates, there were 24 skin isolates and 9 nasal isolates, obtained from 15 of the 63 enrolled dogs, representing 23.8% (95% CI: 14.0–36.2). The 54 oxacillin-susceptible isolates included 43 skin isolates and 11 nasal isolates from 31 dogs, accounting for 49.2% of 63 dogs (95% CI: 36.4–62.1).

3.2. Phenotypic Characteristics of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive S. pseudintermedius

A total of 40 different antibiogram patterns were identified among the 87 S. pseudintermedius isolates, with no predominant antibiogram observed (Figure 1 and Figure 2). All OR-MRSP isolates exhibited multidrug resistance (MDR). Of 33 oxacillin-resistant isolates, 14 antibiogram patterns were identified. The most prevalent MDR pattern among OR-MRSP isolates was resistant to 15 antibiotics including oxacillin, benzylpenicillin, amoxicillin/clavulanic acid, cephalothin, cefpodoxime, cefovecin, gentamicin, enrofloxacin, marbofloxacin, pradofloxacin, erythromycin, clindamycin, doxycycline, minocycline, and chloramphenicol. This pattern was observed in 6 out of the 33 OR-MRSP isolates (18.2%). These six isolates were derived from skin lesions (four isolates) and nasal cavities (two isolates) of two dogs (Figure 1).
Additionally, 24 out of 54 (44.4%) OS-MRSP isolates, derived from skin lesions (20 isolates) and nasal cavities (4 isolates) of 15 dogs, exhibited multidrug resistance, with a total of 20 distinct MDR patterns observed. However, a significant association was found between OR-MRSP isolates and multidrug resistance (MDR) (p ≤ 0.0001), but not with oxacillin-susceptible isolates. Of 26 antibiogram patterns identified among OS-MRSP isolates, the most prevalent pattern was resistance solely to benzylpenicillin (BEN), which was detected in 11 isolates (11/54, 20.4%) originating from skin lesions (9 isolates) and nasal cavities (2 isolates) of eight dogs. Notably, two oxacillin-susceptible isolates from the skin lesions of a single dog exhibited resistance to all beta-lactams tested except for oxacillin (Figure 2).

3.3. Genotypic Characteristics of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius

3.3.1. SCCmec Type

Thirty-nine isolates (39/87, 44.8%) harbored the ccr gene complex 5 (C) and mec gene class C2, classified as SCCmec type V. SCCmec types could not definitively be assigned to 48 isolates (55.2%) due to their combination of ccr and mec gene complexes, which could not be classified using the conventional method outlined by the International Working Group on the Classification of Staphylococcal Cassette Chromosome (2009). Among these non-typeable isolates, 46 carried two ccr gene complexes, 3 had two mec gene complexes, and 9 lacked the mec gene complex altogether. One isolate possessed a novel combination of ccr and mec gene complexes. Details of the SCCmec typing results, using two sets of multiplex PCR, are summarized in Table 2.
The majority (23/33, 69.7%) of OR-MRSP isolates were identified as SCCmec type V, while the remaining 10 isolates could not be classified (Table 3). In contrast, most oxacillin-susceptible isolates were non-typeable (70.4%), with SCCmec type V detected in only 16 isolates (16/54, 29.6%), as shown in Table 4. A significant association was found between SCCmec type V and OR-MRSP isolates, as well as between non-typeable SCCmec types and OS-MRSP isolates, using Fisher’s exact test (p ≤ 0.0004).

3.3.2. Pulsed-Field Gel Electrophoresis (PFGE) Analysis

Out of a total of 87 MRSP isolates, 65 (74.7%) could be digested by SmaI, and 21 (24.1%) by XmaI restriction enzymes, while 1 isolate was resistant to digestion by both enzymes. Among the SmaI-digested isolates, 49 were from skin and 16 from nasal samples, whereas among the XmaI-digested isolates, 18 were from skin and 3 from nasal samples. The undigested isolate originated from a nasal sample. A total of 34 pulsotypes were identified in the SmaI-PFGE dendrogram and 14 pulsotypes were identified in the XmaI-PFGE dendrogram (Supplementary Figures S1 and S2, Table 3 and Table 4). The PFGE analysis revealed diverse patterns across all 87 isolates, including those from both OR-MRSP and OS-MRSP groups, with no predominant pulsotypes observed.

3.4. Comparative Genotypic and Phenotypic Analysis of S. pseudintermedius Isolates from Individual Dogs and Different Dogs

The genotypic characteristics and multidrug-resistant phenotypes of the 33 OR-MRSP and 54 OS-MRSP isolates from each individual dog are presented in Table 3 and Table 4, respectively.
Phenotypically, when two or three OR-MRSP isolates were recovered from a single dog, they exhibited the same antibiogram pattern (Table 3, Figure 1). In contrast, OS-MRSP isolates from a single dog were found to exhibit both identical and different patterns, and both multidrug-resistant (MDR) and non-MDR profiles were observed among isolates originating from a single dog (Table 4, Figure 2).
Genotypically, OR-MRSP isolates from a single dog consistently exhibited the same SCCmec type, irrespective of whether they were obtained from skin lesions or nasal cavities, except for two skin isolates from one dog containing a different ccr complex (Table 3). The SCCmec types of OS-MRSP isolates from the same dog were found to be both uniform and varied, as shown in Table 4. These results parallel the findings of the antibiogram. Based on the chromosomal genomic patterns analyzed by PFGE, no specific patterns were observed in either group. Both OR-MRSP and OS-MRSP isolates from a single dog exhibited both similar and dissimilar pulsotypes. However, isolates with identical pulsotypes were generally derived from different sites on the same dog. Identical pulsotypes were also observed between skin and nasal isolates, while different pulsotypes were noted among skin isolates from individual dogs. With various phenotypes and genotypes observed, no common strains circulated among the dog populations in this study.

4. Discussion

The identification and characterization of mecA-positive S. pseudintermedius isolates from pyoderma-affected dogs provide comprehensive insights into the epidemiology and potential treatment challenges associated with this pathogen and its public health risk. Our study recovered 87 mecA-positive S. pseudintermedius isolates from 46 out of 63 enrolled dogs (73%). This highlights a notable estimated prevalence of S. pseudintermedius carrying the mecA gene among dogs affected by pyoderma. The detection of mecA-positive isolates in both skin and nasal samples aligns with previous findings [25,26], emphasizing the potential for bacterial colonization in multiple anatomical locations. Notably, nasal isolates of OR-MRSP exhibited identical antibiograms and SCCmec types to the infected skin isolates within a single dog. This ability to colonize various sites contributes to its persistent dissemination and potential transfer of resistant genes, thereby complicating treatment and control strategies.
The estimated prevalence of mecA-positive S. pseudintermedius in our study is concerning, as this gene confers resistance to methicillin and other beta-lactam antibiotics commonly used in veterinary practice [27,28]. The OR-MRSP isolates are generally multidrug-resistant, limiting antibiotic treatment options. Although the impact of OS-MRSP is not well understood, there have been reports indicating that OS-MRSA can become inducibly resistant to oxacillin and other beta-lactams after antibiotic exposure [15]. The mechanisms behind the oxacillin susceptibility of these isolates have been reported to include the absence of a complete SCCmec structure except for the mecA gene, as well as mutations or insertions in the mecA gene or its promoter. Revertant isolates containing mutated genes, different from the parental strains, can revert to a resistant phenotype after cefoxitin exposure [15]. Therefore, the isolates with the mecA gene may lead to therapeutic failures, as observed in the previous study involving OS-MRSA in humans [16]. The mechanisms of OS-MRSP isolates in this study necessitate further investigation.
Among the 87 mecA-positive S. pseudintermedius isolates, 33 (37.9%) were classified as oxacillin-resistant, while 54 (62%) were oxacillin-susceptible. Identifying 40 distinct antibiogram patterns with no predominant pattern suggests significant phenotypic diversity and challenges in selecting effective antimicrobial treatments. Multidrug resistance was observed in 65.5% (57/87) of all S. pseudintermedius isolates. In line with previous studies [29,30], our findings, though at a higher proportion, showed that all OR-MRSP isolates exhibited multidrug resistance (MDR), underscoring the significant therapeutic challenges posed by these strains. Additionally, MDR was detected in a significant proportion (24/54, 44.4%) of OS-MRSP isolates. Although most of these isolates were susceptible to extended-spectrum beta-lactam antibiotics, they exhibited resistance to multiple other classes, including tetracyclines, sulphonamides, macrolides, fluoroquinolones, chloramphenicol, and aminoglycosides. A recent study reported an association between the presence of the mecA gene and resistance genes to other antibiotic classes, including aminoglycosides, tetracyclines, lincosamides, and macrolides [31]. Interestingly, two oxacillin-susceptible isolates demonstrated resistance to beta-lactam drugs, except oxacillin. The mechanisms underlying this phenotype and other MDR phenotypes of oxacillin-susceptible isolates require further investigation.
SCCmec type V was found to be the predominant SCCmec type circulating in the study area, located in northeastern Thailand. This finding aligns with global reports indicating that MRSP SCCmec types II-III and V are the two main types widely distributed worldwide, including in Europe and North America [7]. Both types are also prevalent in Asia. Most MRSP isolates in North China and Japan have been identified as SCCmec type II-III [5,32], while most isolates in South China, Thailand, and Korea have been identified as SCCmec type V [33,34,35,36]. In our study, SCCmec type V was identified in 69.7% of the OR-MRSP isolates, demonstrating a strong association between this SCCmec type and its role in disseminating antimicrobial resistance. In contrast, the majority of OS-MRSP isolates were found to carry non-typeable SCCmec elements. The structural differences in SCCmec elements could be a potential reason for the large number of non-typeable isolates among OS-MRSP, similar to what has been observed in OS-MRSA [15].
The inability to type a significant portion of isolates using conventional methods suggests the presence of novel or atypical SCCmec elements or limitations of the SCCmec typing method used. Only two sets of the six multiplex PCRs developed by Kondo et al. [24] were used. According to Turlej et al. [37], these two sets of multiplex PCRs are adequate for characterizing most SCCmec elements and are widely used worldwide. These two sets of multiplex PCRs can identify ccr gene complexes 1 to 5 and mec gene complex classes A, B, and C2. However, ccr gene complexes 6 to 9 cannot be detected; thus, SCCmec types VII, X, XI, XII, and XIII cannot be identified [38,39].
Notably, 38% of the isolates harbored a combination of ccr gene complexes 1 and 5 and mec gene class C2. This SCCmec type was identified in both OR-MRSP and OS-MRSP. A similar result was reported by Chanayat et al. [35], who reported these non-typeable SCCmec elements in 33% (4/12) of MRSP isolates from Chiang Mai province, located in northern Thailand. Additionally, our study identified an SCCmec combination, comprising ccr gene complex class 5 and mec gene complex class A in one isolate (1/87, 1%) of OR-MRSP. This specific SCCmec combination has also been reported in South Africa [39].
For PFGE analysis, more than one restriction enzyme was needed for genomic DNA digestion in our study. Most of the isolates (74.7%) could be digested with SmaI like those reported by previous studies [7,33,40]. The remaining isolates, except one, could be digested with XmaI, the neoschizomers of SmaI. Neoschizomers have the same recognition sequence but are cut at different positions, providing a solution if one enzyme cannot digest an isolate. This case was also experienced by Chanchaithong et al. [33], who used Cfr9I (XmaI) as neoschizomers of SmaI. Sasaki et al. [4] also used XmaI as neoschizomers of SmaI. In addition, they used AscI as a restriction enzyme for isolates that both SmaI and XmaI enzymes could not digest.
The PFGE analysis revealed extensive genetic diversity among the isolates, with 34 pulsotypes identified by SmaI digestion and 14 by XmaI digestion, and no typical or predominant PFGE pulsotypes were identified. These mecA-positive S. pseudintermedius isolates possibly originated from discrete sources, not just from a single source. A similar result of high diversity among isolates was also discovered by previous studies [29,32,33,40,41]. Even though PFGE has high discriminatory power and is considered the gold standard for bacteria typing [42], due to the absence of the standardized PFGE method for S. pseudintermedius, the results obtained between laboratories or between studies have been varied and difficult to compare [43].
The findings of this study underscore the complexity of S. pseudintermedius colonization and infection dynamics in pyoderma-affected dogs. Despite different pulsotypes, the consistent SCCmec types and antibiogram patterns among OR-MRSP isolates from individual dogs suggest the horizontal transfer of SCCmec elements and other antibiotic-resistant genes within hosts. This highlights the role of SCCmec elements in disseminating antibiotic resistance among S. pseudintermedius populations, which can complicate treatment strategies.
In contrast, the variability in phenotypes and genotypes observed among OS-MRSP isolates from a single dog suggests the potential for mixed infections. This finding underscores the importance of comprehensive sampling from multiple sites to characterize resistance profiles and inform effective treatment regimens accurately. The high level of genetic variability, as indicated by the presence of both similar and dissimilar pulsotypes among isolates from the same dog, further complicates the infection dynamics. The detection of identical pulsotypes from different anatomical sites within the same dog indicates that S. pseudintermedius can colonize multiple locations, facilitating its persistence and dissemination.
Our study has limitations due to its sampling strategy, which was confined to diseased dogs. This focus may not fully capture the diversity of the broader canine population. Future research incorporating whole genome analysis could offer a more comprehensive understanding of the genetic relationships among isolates, as well as insights into the antimicrobial resistance mechanisms of both oxacillin-resistant and oxacillin-susceptible mecA-positive S. pseudintermedius.

5. Conclusions

This study underscores the significant challenge posed by mecA-positive S. pseudintermedius in canine pyoderma, particularly due to the high prevalence of multidrug resistance and the genetic diversity of isolates. The findings highlight the necessity for routine mecA screening in diagnostic laboratories to ensure accurate diagnosis and effective treatment. Enhanced surveillance is crucial to managing infections and mitigating the spread of mecA-positive strains. Future research should focus on elucidating the mechanisms underlying the oxacillin susceptibility in mecA-positive S. pseudintermedius isolates and their potential to revert to a resistant phenotype.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/ani14172613/s1; Figure S1: SmaI-pulsed-field gel electrophoresis (PFGE) dendrogram of 65 mecA-positive Staphylococcus pseudintermedius isolates; Figure S2: XmaI-pulsed-field gel electrophoresis (PFGE) dendrogram of 21 mecA-positive Staphylococcus pseudintermedius isolates.

Author Contributions

Conceptualization, P.P. and J.K.; methodology, P.A.S.P., P.P. and J.K.; software, P.A.S.P., validation, P.P., S.J. and J.K.; formal analysis, P.A.S.P.; investigation, P.A.S.P.; resources, P.A.S.P., S.J., P.P. and J.K.; data curation, P.A.S.P.; writing—original draft preparation, P.A.S.P.; writing—review and editing, P.P., J.K. and S.J.; visualization, P.A.S.P. and P.P.; supervision, J.K., S.J. and P.P.; project administration, J.K. and P.P.; funding acquisition, J.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Faculty of Veterinary Medicine, Khon Kaen University, Thailand (Grant No. VM001/2564). PASP received the KKU Active Recruitment Scholarship 2018 for her Ph.D. study.

Institutional Review Board Statement

The study was approved by the Institutional Animal Care and Use Committee of Khon Kaen University (IACUC-KKU-39/62).

Informed Consent Statement

Informed consent was obtained from the owners of 63 dogs involved in this study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors greatly appreciate the Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Khon Kaen University, and all the dog owners for granting permission to collect samples.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Weese, J.S.; van Duijkeren, E. Methicillin-Resistant Staphylococcus aureus and Staphylococcus pseudintermedius in Veterinary Medicine. Vet. Microbiol. 2010, 140, 418–429. [Google Scholar] [CrossRef] [PubMed]
  2. Rubin, J.E.; Chirino-Trejo, M. Prevalence, Sites of Colonization, and Antimicrobial Resistance among Staphylococcus pseudintermedius Isolated from Healthy Dogs in Saskatoon, Canada. J. Vet. Diagn. Investig. 2011, 23, 351–354. [Google Scholar] [CrossRef] [PubMed]
  3. Morris, D.O.; Loeffler, A.; Davis, M.F.; Guardabassi, L.; Weese, J.S. Recommendations for Approaches to Meticillin-Resistant Staphylococcal Infections of Small Animals: Diagnosis, Therapeutic Considerations and Preventative Measures.: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Vet. Dermatol. 2017, 28, 304-e69. [Google Scholar] [CrossRef] [PubMed]
  4. Sasaki, T.; Kikuchi, K.; Tanaka, Y.; Takahashi, N.; Kamata, S.; Hiramatsu, K. Methicillin-Resistant Staphylococcus pseudintermedius in a Veterinary Teaching Hospital. J. Clin. Microbiol. 2007, 45, 1118–1125. [Google Scholar] [CrossRef]
  5. Ishihara, K.; Shimokubo, N.; Sakagami, A.; Ueno, H.; Muramatsu, Y.; Kadosawa, T.; Yanagisawa, C.; Hanaki, H.; Nakajima, C.; Suzuki, Y.; et al. Occurrence and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Methicillin-Resistant Staphylococcus pseudintermedius in an Academic Veterinary Hospital. Appl. Environ. Microbiol. 2010, 76, 5165–5174. [Google Scholar] [CrossRef]
  6. Cuny, C.; Layer-Nicolaou, F.; Weber, R.; Köck, R.; Witte, W. Colonization of Dogs and Their Owners with Staphylococcus aureus and Staphylococcus pseudintermedius in Households, Veterinary Practices, and Healthcare Facilities. Microorganisms 2022, 10, 677. [Google Scholar] [CrossRef] [PubMed]
  7. Perreten, V.; Kadlec, K.; Schwarz, S.; Andersson, U.G.; Finn, M.; Greko, C.; Moodley, A.; Kania, S.A.; Frank, L.A.; Bemis, D.A.; et al. Clonal Spread of Methicillin-Resistant Staphylococcus pseudintermedius in Europe and North America: An International Multicentre Study. J. Antimicrob. Chemother. 2010, 65, 1145–1154. [Google Scholar] [CrossRef]
  8. Magiorakos, A.-P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef]
  9. Ruscher, C.; Lübke-Becker, A.; Wleklinski, C.G.; Şoba, A.; Wieler, L.H.; Walther, B. Prevalence of Methicillin-Resistant Staphylococcus pseudintermedius Isolated from Clinical Samples of Companion Animals and Equidaes. Vet. Microbiol. 2009, 136, 197–201. [Google Scholar] [CrossRef]
  10. Hososaka, Y.; Hanaki, H.; Endo, H.; Suzuki, Y.; Nagasawa, Z.; Otsuka, Y.; Nakae, T.; Sunakawa, K. Characterization of Oxacillin-Susceptible MecA-Positive Staphylococcus aureus: A New Type of MRSA. J. Infect. Chemother. 2007, 13, 79–86. [Google Scholar] [CrossRef]
  11. Saeed, K.; Ahmad, N.; Dryden, M.; Cortes, N.; Marsh, P.; Sitjar, A.; Wyllie, S.; Bourne, S.; Hemming, J.; Jeppesen, C.; et al. Oxacillin-Susceptible Methicillin-Resistant Staphylococcus aureus (OS-MRSA), a Hidden Resistant Mechanism among Clinically Significant Isolates in the Wessex Region/UK. Infection 2014, 42, 843–847. [Google Scholar] [CrossRef]
  12. Conceição, T.; Coelho, C.; de Lencastre, H.; Aires-de-Sousa, M. Frequent Occurrence of Oxacillin-Susceptible MecA-Positive Staphylococcus aureus (OS-MRSA) Strains in Two African Countries. J. Antimicrob. Chemother. 2015, 70, 3200–3204. [Google Scholar] [CrossRef] [PubMed]
  13. Phaku, P.; Lebughe, M.; Strauß, L.; Peters, G.; Herrmann, M.; Mumba, D.; Mellmann, A.; Muyembe-Tamfum, J.J.; Schaumburg, F. Unveiling the Molecular Basis of Antimicrobial Resistance in Staphylococcus aureus from the Democratic Republic of the Congo Using Whole Genome Sequencing. Clin. Microbiol. Infect. 2016, 22, 644-e1. [Google Scholar] [CrossRef] [PubMed]
  14. Liu, J.L.; Li, T.M.; Zhong, N.; Wang, X.; Jiang, J.; Zhang, W.X.; Tang, R.; Guo, Y.J.; Liu, Y.; Hu, J.; et al. Current Status of Oxacillin-Susceptible MecA-Positive Staphylococcus aureus Infection in Shanghai, China: A Multicenter Study. J. Microbiol. Immunol. Infect. 2021, 54, 1070–1077. [Google Scholar] [CrossRef] [PubMed]
  15. Liang, B.; Xiong, Z.; Liang, Z.; Zhang, C.; Cai, H.; Long, Y.; Gao, F.; Wang, J.; Deng, Q.; Zhong, H.; et al. Genomic Basis of Occurrence of Cryptic Resistance among Oxacillin- and Cefoxitin-Susceptible MecA-Positive Staphylococcus aureus. Microbiol. Spectr. 2022, 10, e00291-22. [Google Scholar] [CrossRef]
  16. Duarte, F.C.; Danelli, T.; Tavares, E.R.; Morguette, A.E.B.; Kerbauy, G.; Grion, C.M.C.; Yamauchi, L.M.; Perugini, M.R.E.; Yamada-Ogatta, S.F. Fatal Sepsis Caused by MecA-Positive Oxacillin-Susceptible Staphylococcus aureus: First Report in a Tertiary Hospital of Southern Brazil. J. Infect. Chemother. 2019, 25, 293–297. [Google Scholar] [CrossRef]
  17. Fabri, F.V.; Pinto, N.B.; de Mattos, M.d.S.F.; Rodrigues, R.F.; Shinohara, D.R.; Pereira, P.M.; Nishiyama, S.A.B.; Tognim, M.C.B. First Report of Oxacillin-Susceptible MecA-Positive Staphylococcus aureus in Healthy Dogs and Their Owners in Southern Brazil. Prev. Vet. Med. 2021, 189, 105286. [Google Scholar] [CrossRef]
  18. Putriningsih, P.A.S.; Phuektes, P.; Jittimanee, S.; Kampa, J. Methicillin-Resistant Staphylococci in Canine Pyoderma in Thailand. Vet. World 2023, 16, 2340–2348. [Google Scholar] [CrossRef]
  19. Sasaki, T.; Tsubakishita, S.; Tanaka, Y.; Sakusabe, A.; Ohtsuka, M.; Hirotaki, S.; Kawakami, T.; Fukata, T.; Hiramatsu, K. Multiplex-PCR Method for Species Identification of Coagulase-Positive Staphylococci. J. Clin. Microbiol. 2010, 48, 765–769. [Google Scholar] [CrossRef]
  20. Oliveira, D.C.; De Lencastre, H. Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the Mec Element in Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 46, 2155–2161. [Google Scholar] [CrossRef]
  21. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 5th ed.; CLSI Supplement VET01S; CLSI: Wayne, PA, USA, 2020; Volume 40. [Google Scholar]
  22. Skov, R.; Varga, A.; Matuschek, E.; Åhman, J.; Bemis, D.; Bengtsson, B.; Sunde, M.; Humphries, R.; Westblade, L.; Guardabassi, L.; et al. EUCAST Disc Diffusion Criteria for the Detection of MecA-Mediated β-Lactam Resistance in Staphylococcus pseudintermedius: Oxacillin versus Cefoxitin. Clin. Microbiol. Infect. 2020, 26, 122.e1–122.e6. [Google Scholar] [CrossRef] [PubMed]
  23. He, Y.; Xie, Y.; Reed, S. Pulsed-Field Gel Electrophoresis Typing of Staphylococcus aureus Isolates. In Methicillin-Resistant Staphylococcus Aureus (MRSA) Protocols; Methods in Molecular Biology; Humana Press: Totowa, NJ, USA, 2014; Volume 1085. [Google Scholar] [CrossRef]
  24. Kondo, Y.; Ito, T.; Ma, X.X.; Watanabe, S.; Kreiswirth, B.N.; Etienne, J.; Hiramatsu, K. Combination of Multiplex PCRs for Staphylococcal Cassette Chromosome Mec Type Assignment: Rapid Identification System for Mec, Ccr, and Major Differences in Junkyard Regions. Antimicrob. Agents Chemother. 2007, 51, 264–274. [Google Scholar] [CrossRef] [PubMed]
  25. Fungwithaya, P.; Chanchaithong, P.; Phumthanakorn, N.; Prapasarakul, N. Nasal Carriage of Methicillin-Resistant Staphylococcus pseudintermedius in Dogs Treated with Cephalexin Monohydrate. Can. Vet. J. 2017, 58, 73. [Google Scholar] [PubMed]
  26. Abdullahi, I.N.; Zarazaga, M.; Campaña-Burguet, A.; Eguizábal, P.; Lozano, C.; Torres, C. Nasal Staphylococcus aureus and S. pseudintermedius Carriage in Healthy Dogs and Cats: A Systematic Review of Their Antibiotic Resistance, Virulence and Genetic Lineages of Zoonotic Relevance. J. Appl. Microbiol. 2022, 133, 3368–3390. [Google Scholar] [CrossRef]
  27. Weese, J.S.; Battersby, I.; Morrison, J.A.; Spofford, N.; Soltero-Rivera, M. Antimicrobial Use Practices in Canine and Feline Dental Procedures Performed in Primary Care Veterinary Practices in the United States. PLoS ONE 2023, 18, e0295070. [Google Scholar] [CrossRef] [PubMed]
  28. Murphy, C.P.; Reid-Smith, R.J.; Boerlin, P.; Weese, J.S.; Prescott, J.F.; Janecko, N.; McEwen, S.A. Out-Patient Antimicrobial Drug Use in Dogs and Cats for New Disease Events from Community Companion Animal Practices in Ontario. Can. Vet. J. 2012, 53, 291. [Google Scholar]
  29. Gagetti, P.; Wattam, A.R.; Giacoboni, G.; De Paulis, A.; Bertona, E.; Corso, A.; Rosato, A.E. Identification and Molecular Epidemiology of Methicillin Resistant Staphylococcus pseudintermedius Strains Isolated from Canine Clinical Samples in Argentina. BMC Vet. Res. 2019, 15, 264. [Google Scholar] [CrossRef]
  30. Viegas, F.M.; Santana, J.A.; Silva, B.A.; Xavier, R.G.C.; Bonisson, C.T.; Câmara, J.L.S.; Rennó, M.C.; Cunha, J.L.R.; Figueiredo, H.C.P.; Lobato, F.C.F.; et al. Occurrence and Characterization of Methicillin-Resistant Staphylococcus Spp. in Diseased Dogs in Brazil. PLoS ONE 2022, 17, e0269422. [Google Scholar] [CrossRef]
  31. Viñes, J.; Fàbregas, N.; Pérez, D.; Cuscó, A.; Fonticoba, R.; Francino, O.; Ferrer, L.; Migura-Garcia, L. Concordance between Antimicrobial Resistance Phenotype and Genotype of Staphylococcus pseudintermedius from Healthy Dogs. Antibiotics 2022, 11, 1625. [Google Scholar] [CrossRef]
  32. Wang, Y.; Yang, J.; Logue, C.M.; Liu, K.; Cao, X.; Zhang, W.; Shen, J.; Wu, C. Methicillin-Resistant Staphylococcus pseudintermedius Isolated from Canine Pyoderma in North China. J. Appl. Microbiol. 2012, 112, 623–630. [Google Scholar] [CrossRef]
  33. Chanchaithong, P.; Perreten, V.; Schwendener, S.; Tribuddharat, C.; Chongthaleong, A.; Niyomtham, W.; Prapasarakul, N. Strain Typing and Antimicrobial Susceptibility of Methicillin-Resistant Coagulase-Positive Staphylococcal Species in Dogs and People Associated with Dogs in Thailand. J. Appl. Microbiol. 2014, 117, 572–586. [Google Scholar] [CrossRef]
  34. Feng, Y.; Tian, W.; Lin, D.; Luo, Q.; Zhou, Y.; Yang, T.; Deng, Y.; Liu, Y.H.; Liu, J.H. Prevalence and Characterization of Methicillin-Resistant Staphylococcus pseudintermedius in Pets from South China. Vet. Microbiol. 2012, 160, 517–524. [Google Scholar] [CrossRef] [PubMed]
  35. Chanayat, Y.; Akatvipat, A.; Bender, J.B.; Punyapornwithaya, V.; Meeyam, T.; Anukool, U.; Pichpol, D. The Sccmec Types and Antimicrobial Resistance among Methicillin-Resistant Staphylococcus Species Isolated from Dogs with Superficial Pyoderma. Vet. Sci. 2021, 8, 85. [Google Scholar] [CrossRef]
  36. Kang, J.H.; Chung, T.H.; Hwang, C.Y. Clonal Distribution of Methicillin-Resistant Staphylococcus pseudintermedius Isolates from Skin Infection of Dogs in Korea. Vet. Microbiol. 2017, 210, 32–37. [Google Scholar] [CrossRef]
  37. Turlej, A.; Hryniewicz, W.; Empel, J. Staphylococcal Cassette Chromosome Mec (SCCmec) Classification and Typing Methods: An Overview. Pol. J. Microbiol. 2011, 60, 95–103. [Google Scholar] [CrossRef] [PubMed]
  38. Baig, S.; Johannesen, T.B.; Overballe-Petersen, S.; Larsen, J.; Larsen, A.R.; Stegger, M. Novel SCCmec Type XIII (9A) Identified in an ST152 Methicillin-Resistant Staphylococcus aureus. Infect. Genet. Evol. 2018, 61, 74–76. [Google Scholar] [CrossRef] [PubMed]
  39. Singh-Moodley, A.; Strasheim, W.; Mogokotleng, R.; Ismail, H.; Perovic, O. Unconventional SCCmec Types and Low Prevalence of the Panton-Valentine Leukocidin Exotoxin in South African Blood Culture Staphylococcus aureus Surveillance Isolates, 2013–2016. PLoS ONE 2019, 14, e0225726. [Google Scholar] [CrossRef]
  40. Nienhoff, U.; Kadlec, K.; Chaberny, I.F.; Verspohl, J.; Gerlach, G.F.; Kreienbrock, L.; Schwarz, S.; Simon, D.; Nolte, I. Methicillin-Resistant Staphylococcus pseudintermedius among Dogs Admitted to a Small Animal Hospital. Vet. Microbiol. 2011, 150, 191–197. [Google Scholar] [CrossRef]
  41. Kadlec, K.; Weiß, S.; Wendlandt, S.; Schwarz, S.; Tonpitak, W. Characterization of Canine and Feline Methicillin-Resistant Staphylococcus pseudintermedius (MRSP) from Thailand. Vet. Microbiol. 2016, 194, 93–97. [Google Scholar] [CrossRef]
  42. Neoh, H.; Tan, X.-E.; Sapri, H.F.; Tan, T.L. Pulsed-Field Gel Electrophoresis (PFGE): A Review of the “Gold Standard” for Bacteria Typing and Current Alternatives. Infect. Genet. Evol. 2019, 74, 103935. [Google Scholar] [CrossRef]
  43. Fazakerley, J.; Williams, N.; Carter, S.; McEwan, N.; Nuttall, T. Heterogeneity of Staphylococcus pseudintermedius Isolates from Atopic and Healthy Dogs. Vet. Dermatol. 2010, 21, 578–585. [Google Scholar] [CrossRef] [PubMed]
Animals 14 02613 g001
Figure 1. Heat map illustrating the antibiogram patterns of 33 oxacillin-resistant mecA-positive Staphylococcus pseudintermedius (OR-MRSP) isolates. Antimicrobial susceptibility was assessed using the VITEK® 2 system. Each row represents an individual isolate, labelled by the dog number from which it was obtained, the sample origin (skin lesion or nasal swab), and the corresponding isolate number from each dog. The heat map employs a color gradient where dark blue boxes indicate resistance, light blue boxes represent intermediate susceptibility, and white boxes represent susceptibility to the tested antibiotics.
Figure 1. Heat map illustrating the antibiogram patterns of 33 oxacillin-resistant mecA-positive Staphylococcus pseudintermedius (OR-MRSP) isolates. Antimicrobial susceptibility was assessed using the VITEK® 2 system. Each row represents an individual isolate, labelled by the dog number from which it was obtained, the sample origin (skin lesion or nasal swab), and the corresponding isolate number from each dog. The heat map employs a color gradient where dark blue boxes indicate resistance, light blue boxes represent intermediate susceptibility, and white boxes represent susceptibility to the tested antibiotics.
Animals 14 02613 g001
Animals 14 02613 g002
Figure 2. Heat map illustrating the antibiogram patterns of 54 oxacillin-susceptible mecA-positive Staphylococcus pseudintermedius (OS-MRSP) isolates. Antimicrobial susceptibility was assessed using the VITEK® 2 system. Each row represents an individual isolate, labelled by the dog number from which it was obtained, the sample origin (skin lesion or nasal swab), and the corresponding isolate number from each dog. The heat map employs a color gradient where dark blue boxes indicate resistance, light blue boxes represent intermediate susceptibility, and white boxes represent susceptibility to the tested antibiotics.
Figure 2. Heat map illustrating the antibiogram patterns of 54 oxacillin-susceptible mecA-positive Staphylococcus pseudintermedius (OS-MRSP) isolates. Antimicrobial susceptibility was assessed using the VITEK® 2 system. Each row represents an individual isolate, labelled by the dog number from which it was obtained, the sample origin (skin lesion or nasal swab), and the corresponding isolate number from each dog. The heat map employs a color gradient where dark blue boxes indicate resistance, light blue boxes represent intermediate susceptibility, and white boxes represent susceptibility to the tested antibiotics.
Animals 14 02613 g002
Table 1. Sample origins and distribution of Staphylococcus pseudintermedius isolates positive for the mecA gene recovered from 46 enrolled dogs.
Table 1. Sample origins and distribution of Staphylococcus pseudintermedius isolates positive for the mecA gene recovered from 46 enrolled dogs.
Origin of SamplesNumber of Dogs (n)
One IsolateTwo Isolates 1Three Isolates 2
Skin lesions9170
Nasal cavity600
Skin lesions and nasal cavity0410
1 Isolates were obtained from two different sites on the dog. 2 Two isolates were from skin lesions, and another isolate was from a nasal swab.
Table 2. Characteristics of typeable and non-typeable SCCmec Staphylococcus pseudintermedius isolates.
Table 2. Characteristics of typeable and non-typeable SCCmec Staphylococcus pseudintermedius isolates.
ccr Gene Complexmec Gene ComplexSCCmec TypeTotal Isolates (%)
5 (C)C2V 39/87 (45)
1 (A1B1) and 5 (C)C2NT33/87 (38)
1 (A1B1) and 5 (C)ANT 2/87 (2)
2 (A2B2) and 5 (C)B and C2NT2/87 (2)
1 (A1B1)A and C2NT1/87 (1)
1 (A1B1) and 5 (C)NegativeNT9/87 (10)
5 (C)ANT (5A, new combination)1/87 (1)
NT, non-typeable.
Table 3. Genotypic characteristics and multidrug-resistant phenotypes of 33 oxacillin-resistant mecA-positive Staphylococcus pseudintermedius (OR-MRSP) isolates.
Table 3. Genotypic characteristics and multidrug-resistant phenotypes of 33 oxacillin-resistant mecA-positive Staphylococcus pseudintermedius (OR-MRSP) isolates.
Dog
No.		Isolate
Code		Origin of SampleMR/MS
Phenotype		MDR PhenotypePFGE PulsotypeSCCmec Typing
ccr Gene Complexmec Gene ComplexSCCmec Type
44 S1SkinMRMDRSmaI-AH5 (C)ANT
4 S2SkinMRMDRXmaI-D5 (C), 1 (A1B1)ANT
66 S1SkinMRMDRSmaI-B5 (C), 1 (A1B1)C2NT
6 S2SkinMRMDRSmaI-B5 (C), 1 (A1B1)C2NT
6 N1NasalMRMDRSmaI-B5 (C), 1 (A1B1)C2NT
1111 N1NasalMRMDRXmaI-C5 (C)C2V
1212 S1SkinMRMDRXmaI-E5 (C)C2V
12 S2SkinMRMDRXmaI-E5 (C)C2V
12 N1NasalMRMDRnt5 (C)C2V
1818 S1SkinMRMDRSmaI-K5 (C)C2V
18 S2SkinMRMDRXmaI-I5 (C)C2V
18 N1NasalMRMDRXmaI-I5 (C)C2V
1919 S1SkinMRMDRSmaI-E5 (C), 1 (A1B1)C2NT
19 S2SkinMRMDRSmaI-A5 (C)C2V
2323 S2SkinMRMDRSmaI-AB5 (C)C2V
23 N1NasalMRMDRSmaI-AB5 (C)C2V
2626 S1SkinMRMDRSmaI-S5 (C)C2V
26 S2SkinMRMDRSmaI-I5 (C)C2V
3232 S1SkinMRMDRXmaI-G5 (C), 2 (A2B2)B, C2NT
32S2SkinMRMDRXmaI-G5 (C), 2 (A2B2)B, C2NT
3333 S1SkinMRMDRSmaI-AE5 (C)C2V
33 S2SkinMRMDRSmaI-AE5 (C)C2V
3636 N1NasalMRMDRSmaI-AB5 (C), 1 (A1B1)C2NT
4141 S1SkinMRMDRSmaI-AB5 (C)C2V
41 S2SkinMRMDRSmaI-AB5 (C)C2V
41 N1NasalMRMDRSmaI-G5 (C)C2V
4242 S1SkinMRMDRSmaI-D5 (C)C2V
42 S2SkinMRMDRXmaI-M5 (C)C2V
42 N1NasalMRMDRSmaI-M5 (C)C2V
4343 S1SkinMRMDRSmaI-AG5 (C)C2V
43 S2SkinMRMDRSmaI-AC5 (C)C2V
43 N1NasalMRMDRSmaI-AC5 (C)C2V
5757 S2SkinMRMDRSmaI-C5 (C), 1 (A1B1)C2NT
nt, not tested; NT, non-typeable; MR/MS, methicillin-resistant/methicillin-susceptible (based on VITEK results and oxacillin disk diffusion test); MDR, multidrug-resistant (based on VITEK results); Pos, positive; Neg, negative.
Table 4. Genotypic characteristics and multidrug-resistant phenotypes of 54 oxacillin-susceptible mecA-positive Staphylococcus pseudintermedius (OS-MRSP) isolates.
Table 4. Genotypic characteristics and multidrug-resistant phenotypes of 54 oxacillin-susceptible mecA-positive Staphylococcus pseudintermedius (OS-MRSP) isolates.
Dog
No.		Isolates CodeOrigin of SampleMR/MS
Phenotype		MDR PhenotypePFGE PulsotypeSCCmec Typing
ccr Gene Complexmec Gene ComplexSCCmec Type
77 S2SkinMSNOSmaI-Y5 (C), 1 (A1B1)C2NT
88 S1SkinMSMDRSmaI-A5 (C), 1 (A1B1)C2NT
8 S2SkinMSMDRSmaI-A5 (C), 1 (A1B1)C2NT
99 S1SkinMSMDRSmaI-A5 (C), 1 (A1B1)(-)NT
9 S2SkinMSMDRSmaI-R5 (C), 1 (A1B1)(-)NT
9 N1NasalMSMDRSmaI-F5 (C)C2V
1010 S2SkinMSMDRSmaI-P5 (C), 1 (A1B1)(-)NT
1313 S1SkinMSNOXmaI-L5 (C), 1 (A1B1)C2NT
13 S2SkinMSNOXmaI-J5 (C), 1 (A1B1)ANT
1515 S1SkinMSNOSmaI-V5 (C), 1 (A1B1)(-)NT
15 S2SkinMSNOSmaI-L5 (C), 1 (A1B1)A, C2NT
1616 S1SkinMSNOSmaI-A5 (C), 1 (A1B1)(-)NT
1717 S2SkinMSNOSmaI-H5 (C), 1 (A1B1)(-)NT
17 N1NasalMSNOSmaI-V5 (C), 1 (A1B1)C2NT
2020 S1SkinMSNOXmaI-F5 (C), 1 (A1B1)C2NT
20 S2SkinMSNOSmaI-E5 (C), 1 (A1B1)(-)NT
2121 N1NasalMSNOSmaI-W5 (C)C2V
2222 S1SkinMSNOSmaI-L5 (C), 1 (A1B1)C2NT
2525 S1SkinMSMDRXmaI-K5 (C), 1 (A1B1)(-)NT
25 S2SkinMSMDRXmaI-K5 (C), 1 (A1B1)C2NT
2727 S1SkinMSNOSmaI-N5 (C), 1 (A1B1)C2NT
27 S2SkinMSNOSmaI-N5 (C), 1 (A1B1)(-)NT
2828 S1SkinMSNOSmaI-O5 (C), 1 (A1B1)C2NT
2929 S2SkinMSNOSmaI-G5 (C), 1 (A1B1)C2NT
3030 S1SkinMSNOSmaI-AE5 (C)C2V
30 S2SkinMSNOSmaI-AE5 (C)C2V
3131 S2SkinMSNOXmaI-N5 (C)C2V
31 N1NasalMSNOXmaI-N5 (C)C2V
3434 S1SkinMSMDRSmaI-U5 (C), 1 (A1B1)C2NT
34 S2SkinMSMDRSmaI-U5 (C), 1 (A1B1)C2NT
3535 S2SkinMSMDRXmaI-H 5 (C)C2V
3737 N1NasalMSNOSmaI-Q 5 (C)C2V
4444 S1SkinMSNOSmaI-Z5 (C)C2V
44 S2SkinMSNOSmaI-AA5 (C), 1 (A1B1)C2NT
44 N1NasalMSNOSmaI-V5 (C)C2V
4545 N1NasalMSNOSmaI-AF5 (C), 1 (A1B1)C2NT
4646 S1SkinMSMDRSmaI-E5 (C), 1 (A1B1)C2NT
46 S2SkinMSMDRSmaI-E5 (C), 1 (A1B1)C2NT
4848 S1SkinMSMDRSmaI-V5 (C), 1 (A1B1) C2NT
48 S2SkinMSNOSmaI-C5 (C), 1 (A1B1) C2NT
4949 S1SkinMSMDRXmaI-A5 (C), 1 (A1B1) C2NT
49 S2SkinMSMDRXmaI-A5 (C), 1 (A1B1) C2NT
5656 S1SkinMSNOSmaI-V5 (C) C2V
56 S2SkinMSNOSmaI-AD5 (C) C2V
56 N1NasalMSMDRSmaI-T5 (C), 1 (A1B1) C2NT
5858 S2SkinMSMDRXmaI-B5 (C), 1 (A1B1)C2NT
58 N1NasalMSMDRSmaI-J5 (C), 1 (A1B1)C2NT
5959 S2SkinMSMDRXmaI-B5 (C), 1 (A1B1)C2NT
6060 S1SkinMSMDRSmaI-R5 (C)C2V
60 S2SkinMSNOSmaI-X5 (C), 1 (A1B1)C2NT
60 N1NasalMSNOSmaI-X5 (C), 1 (A1B1)C2NT
6262 N1NasalMSMDRSmaI-A5 (C)C2V
6363 S1SkinMSMDRSmaI-R5 (C)C2V
63 S2SkinMSMDRSmaI-R5 (C)C2V
NT, non-typeable; MR/MS, methicillin-resistant/methicillin-susceptible (based on VITEK results and oxacillin disk diffusion test); MDR, multidrug-resistant (based on VITEK results).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Putriningsih, P.A.S.; Kampa, J.; Jittimanee, S.; Phuektes, P. Characterization of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius from Skin Lesions and Nasal Cavities of Dogs with Clinical Pyoderma. Animals 2024, 14, 2613. https://doi.org/10.3390/ani14172613

AMA Style

Putriningsih PAS, Kampa J, Jittimanee S, Phuektes P. Characterization of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius from Skin Lesions and Nasal Cavities of Dogs with Clinical Pyoderma. Animals. 2024; 14(17):2613. https://doi.org/10.3390/ani14172613

Chicago/Turabian Style

Putriningsih, Putu Ayu Sisyawati, Jaruwan Kampa, Suphattra Jittimanee, and Patchara Phuektes. 2024. "Characterization of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius from Skin Lesions and Nasal Cavities of Dogs with Clinical Pyoderma" Animals 14, no. 17: 2613. https://doi.org/10.3390/ani14172613

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop